APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor XIII

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Coagulation Factor XIII Industry Growth and Trends Forecast to 2032

29 December 202599 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor XIII Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor XIII Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor XIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor XIII Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor XIII Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Human Coagulation Factor XIII market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Coagulation Factor XIII is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Coagulation Factor XIII is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Coagulation Factor XIII is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Coagulation Factor XIII include Cell Sciences, Inc., CSL Behring, Enzyme Research Laboratories Inc., Invitrogen (Thermo Fisher Scientific Inc.), Sino Biological, Inc., ZEDIRA GmbH and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Coagulation Factor XIII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Coagulation Factor XIII market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Coagulation Factor XIII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Coagulation Factor XIII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Coagulation Factor XIII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Coagulation Factor XIII Market by Company

Cell Sciences, Inc.

CSL Behring

Enzyme Research Laboratories Inc.

Invitrogen (Thermo Fisher Scientific Inc.)

Sino Biological, Inc.

ZEDIRA GmbH

Merck KGaA

Human Coagulation Factor XIII Segment by Type

Lyophilized Powder

Liquid

Human Coagulation Factor XIII Segment by Application

Medical Research

Surgery

Disease Treatment

Others

Human Coagulation Factor XIII Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor XIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor XIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor XIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor XIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Coagulation Factor XIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lyophilized Powder Table 2. Major Company of Liquid Table 3. Global Human Coagulation Factor XIII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 5. Global Human Coagulation Factor XIII Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Coagulation Factor XIII Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Coagulation Factor XIII Price by Type (2021-2026) & (US$/Kg) Table 9. Global Human Coagulation Factor XIII Sales by Type (2027-2032) & (Kg) Table 10. Global Human Coagulation Factor XIII Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Coagulation Factor XIII Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Coagulation Factor XIII Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Coagulation Factor XIII Price by Type (2027-2032) & (US$/Kg) Table 14. North America Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 15. North America Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 17. Europe Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 21. Latin America Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Coagulation Factor XIII Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Human Coagulation Factor XIII Sales by Type (2021-2026) & (US$ Million) Table 24. Human Coagulation Factor XIII Industry Trends Table 25. Human Coagulation Factor XIII Industry Drivers Table 26. Human Coagulation Factor XIII Industry Opportunities and Challenges Table 27. Human Coagulation Factor XIII Industry Restraints Table 28. Global Human Coagulation Factor XIII Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Coagulation Factor XIII Revenue Market Share by Company (2021-2026) Table 30. Global Human Coagulation Factor XIII Sales by Company (2021-2026) & (Kg) Table 31. Global Human Coagulation Factor XIII Sales Share by Company (2021-2026) Table 32. Global Human Coagulation Factor XIII Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Human Coagulation Factor XIII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Coagulation Factor XIII Major Company Production Sites and Headquarters Table 35. Global Human Coagulation Factor XIII Company, Product Type & Application Table 36. Global Human Coagulation Factor XIII Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Coagulation Factor XIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Coagulation Factor XIII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Coagulation Factor XIII Sales by Region (2021-2026) & (Kg) Table 41. Global Human Coagulation Factor XIII Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Coagulation Factor XIII Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Coagulation Factor XIII Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Coagulation Factor XIII Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Human Coagulation Factor XIII Sales by Region (2027-2032) & (Kg) Table 46. Global Human Coagulation Factor XIII Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Coagulation Factor XIII Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Coagulation Factor XIII Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Coagulation Factor XIII Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Human Coagulation Factor XIII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 52. Global Human Coagulation Factor XIII Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Coagulation Factor XIII Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Coagulation Factor XIII Price by Application (2021-2026) & (US$/Kg) Table 56. Global Human Coagulation Factor XIII Sales by Application (2027-2032) & (Kg) Table 57. Global Human Coagulation Factor XIII Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Coagulation Factor XIII Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Coagulation Factor XIII Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Coagulation Factor XIII Price by Application (2027-2032) & (US$/Kg) Table 61. North America Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 62. North America Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 64. Europe Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 68. Latin America Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Coagulation Factor XIII Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Human Coagulation Factor XIII Sales by Application (2021-2026) & (US$ Million) Table 71. Cell Sciences, Inc. Company Information Table 72. Cell Sciences, Inc. Business Overview Table 73. Cell Sciences, Inc. Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Cell Sciences, Inc. Human Coagulation Factor XIII Product Portfolio Table 75. Cell Sciences, Inc. Recent Development Table 76. CSL Behring Company Information Table 77. CSL Behring Business Overview Table 78. CSL Behring Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. CSL Behring Human Coagulation Factor XIII Product Portfolio Table 80. CSL Behring Recent Development Table 81. Enzyme Research Laboratories Inc. Company Information Table 82. Enzyme Research Laboratories Inc. Business Overview Table 83. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Portfolio Table 85. Enzyme Research Laboratories Inc. Recent Development Table 86. Invitrogen (Thermo Fisher Scientific Inc.) Company Information Table 87. Invitrogen (Thermo Fisher Scientific Inc.) Business Overview Table 88. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Portfolio Table 90. Invitrogen (Thermo Fisher Scientific Inc.) Recent Development Table 91. Sino Biological, Inc. Company Information Table 92. Sino Biological, Inc. Business Overview Table 93. Sino Biological, Inc. Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Sino Biological, Inc. Human Coagulation Factor XIII Product Portfolio Table 95. Sino Biological, Inc. Recent Development Table 96. ZEDIRA GmbH Company Information Table 97. ZEDIRA GmbH Business Overview Table 98. ZEDIRA GmbH Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. ZEDIRA GmbH Human Coagulation Factor XIII Product Portfolio Table 100. ZEDIRA GmbH Recent Development Table 101. Merck KGaA Company Information Table 102. Merck KGaA Business Overview Table 103. Merck KGaA Human Coagulation Factor XIII Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Merck KGaA Human Coagulation Factor XIII Product Portfolio Table 105. Merck KGaA Recent Development Table 106. North America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 107. North America Human Coagulation Factor XIII Sales by Country (2021-2026) & (Kg) Table 108. North America Human Coagulation Factor XIII Sales Market Share by Country (2021-2026) Table 109. North America Human Coagulation Factor XIII Sales Forecast by Country (2027-2032) & (Kg) Table 110. North America Human Coagulation Factor XIII Sales Market Share Forecast by Country (2027-2032) Table 111. North America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Human Coagulation Factor XIII Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Human Coagulation Factor XIII Market Share by Country (2021-2026) Table 114. North America Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Human Coagulation Factor XIII Market Share Forecast by Country (2027-2032) Table 116. Europe Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 117. Europe Human Coagulation Factor XIII Sales by Country (2021-2026) & (Kg) Table 118. Europe Human Coagulation Factor XIII Sales Market Share by Country (2021-2026) Table 119. Europe Human Coagulation Factor XIII Sales Forecast by Country (2027-2032) & (Kg) Table 120. Europe Human Coagulation Factor XIII Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Human Coagulation Factor XIII Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Human Coagulation Factor XIII Market Share by Country (2021-2026) Table 124. Europe Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Human Coagulation Factor XIII Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Human Coagulation Factor XIII Sales by Country (2021-2026) & (Kg) Table 128. Asia-Pacific Human Coagulation Factor XIII Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Human Coagulation Factor XIII Sales Forecast by Country (2027-2032) & (Kg) Table 130. Asia-Pacific Human Coagulation Factor XIII Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Human Coagulation Factor XIII Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Human Coagulation Factor XIII Market Share by Country (2021-2026) Table 134. Asia-Pacific Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Human Coagulation Factor XIII Market Share Forecast by Country (2027-2032) Table 136. Latin America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 137. Latin America Human Coagulation Factor XIII Sales by Country (2021-2026) & (Kg) Table 138. Latin America Human Coagulation Factor XIII Sales Market Share by Country (2021-2026) Table 139. Latin America Human Coagulation Factor XIII Sales Forecast by Country (2027-2032) & (Kg) Table 140. Latin America Human Coagulation Factor XIII Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Human Coagulation Factor XIII Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Human Coagulation Factor XIII Market Share by Country (2021-2026) Table 144. Latin America Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Human Coagulation Factor XIII Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Human Coagulation Factor XIII Sales by Country (2021-2026) & (Kg) Table 148. Middle East and Africa Human Coagulation Factor XIII Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Human Coagulation Factor XIII Sales Forecast by Country (2027-2032) & (Kg) Table 150. Middle East and Africa Human Coagulation Factor XIII Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Human Coagulation Factor XIII Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Human Coagulation Factor XIII Market Share by Country (2021-2026) Table 154. Middle East and Africa Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Human Coagulation Factor XIII Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Human Coagulation Factor XIII Distributors List Table 159. Human Coagulation Factor XIII Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Human Coagulation Factor XIII Image Figure 2. Global Human Coagulation Factor XIII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor XIII Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor XIII Sales (2021-2032) & (Kg) Figure 5. Lyophilized Powder Image Figure 6. Global Lyophilized Powder Sales YoY Growth (2021-2032) & (Kg) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Human Coagulation Factor XIII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Coagulation Factor XIII Market Share by Type 2025 VS 2032 Figure 11. North America Human Coagulation Factor XIII Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Coagulation Factor XIII Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Coagulation Factor XIII Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Coagulation Factor XIII Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Coagulation Factor XIII Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Coagulation Factor XIII Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Coagulation Factor XIII Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Coagulation Factor XIII Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Coagulation Factor XIII Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Coagulation Factor XIII Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Coagulation Factor XIII Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medical Research Image Figure 24. Global Medical Research Sales YoY Growth (2021-2032) & (Kg) Figure 25. Surgery Image Figure 26. Global Surgery Sales YoY Growth (2021-2032) & (Kg) Figure 27. Disease Treatment Image Figure 28. Global Disease Treatment Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Human Coagulation Factor XIII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Coagulation Factor XIII Market Share by Application 2025 VS 2032 Figure 33. North America Human Coagulation Factor XIII Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Coagulation Factor XIII Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Coagulation Factor XIII Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Coagulation Factor XIII Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Coagulation Factor XIII Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Coagulation Factor XIII Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Coagulation Factor XIII Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Coagulation Factor XIII Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Coagulation Factor XIII Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Coagulation Factor XIII Sales Market Share in Value by Application in 2025 Figure 43. North America Human Coagulation Factor XIII Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Human Coagulation Factor XIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Coagulation Factor XIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Coagulation Factor XIII Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Human Coagulation Factor XIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Coagulation Factor XIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Coagulation Factor XIII Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Human Coagulation Factor XIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Coagulation Factor XIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Coagulation Factor XIII Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Human Coagulation Factor XIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Coagulation Factor XIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Coagulation Factor XIII Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Human Coagulation Factor XIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Coagulation Factor XIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Coagulation Factor XIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Coagulation Factor XIII Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Coagulation Factor XIII Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized Powder
  • Liquid
Applications
  • Medical Research
  • Surgery
  • Disease Treatment
  • Others
Companies covered
  • Cell Sciences, Inc.
  • CSL Behring
  • Enzyme Research Laboratories Inc.
  • Invitrogen (Thermo Fisher Scientific Inc.)
  • Sino Biological, Inc.
  • ZEDIRA GmbH
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Coagulation Factor XIII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Coagulation Factor XIII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Coagulation Factor XIII Market by Type
  6. 1.3.1 Lyophilized Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Human Coagulation Factor XIII Market Size by Type
  9. 1.4.1 Global Human Coagulation Factor XIII Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Coagulation Factor XIII Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Coagulation Factor XIII Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Coagulation Factor XIII Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Coagulation Factor XIII Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Coagulation Factor XIII Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Coagulation Factor XIII Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Coagulation Factor XIII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Coagulation Factor XIII Industry Trends
  2. 2.2 Human Coagulation Factor XIII Industry Drivers
  3. 2.3 Human Coagulation Factor XIII Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor XIII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Coagulation Factor XIII Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Coagulation Factor XIII Sales (2021-2026)
  3. 3.3 Global Top Players by Human Coagulation Factor XIII Price (2021-2026)
  4. 3.4 Global Human Coagulation Factor XIII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor XIII Major Company Production Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor XIII Company, Product Type & Application
  7. 3.7 Global Human Coagulation Factor XIII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor XIII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor XIII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor XIII Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor XIII Regional Status and Outlook
  1. 4.1 Global Human Coagulation Factor XIII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Coagulation Factor XIII Historic Market Size by Region
  3. 4.2.1 Global Human Coagulation Factor XIII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Coagulation Factor XIII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Coagulation Factor XIII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Coagulation Factor XIII Forecasted Market Size by Region
  7. 4.3.1 Global Human Coagulation Factor XIII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Coagulation Factor XIII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Coagulation Factor XIII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Coagulation Factor XIII by Application
  1. 5.1 Human Coagulation Factor XIII Market by Application
  2. 5.1.1 Medical Research
  3. 5.1.2 Surgery
  4. 5.1.3 Disease Treatment
  5. 5.1.4 Others
  6. 5.2 Global Human Coagulation Factor XIII Market Size by Application
  7. 5.2.1 Global Human Coagulation Factor XIII Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Coagulation Factor XIII Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Coagulation Factor XIII Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Coagulation Factor XIII Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Coagulation Factor XIII Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Coagulation Factor XIII Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Coagulation Factor XIII Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Coagulation Factor XIII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cell Sciences, Inc.
  2. 6.1.1 Cell Sciences, Inc. Company Information
  3. 6.1.2 Cell Sciences, Inc. Business Overview
  4. 6.1.3 Cell Sciences, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cell Sciences, Inc. Human Coagulation Factor XIII Product Portfolio
  6. 6.1.5 Cell Sciences, Inc. Recent Developments
  7. 6.2 CSL Behring
  8. 6.2.1 CSL Behring Company Information
  9. 6.2.2 CSL Behring Business Overview
  10. 6.2.3 CSL Behring Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Behring Human Coagulation Factor XIII Product Portfolio
  12. 6.2.5 CSL Behring Recent Developments
  13. 6.3 Enzyme Research Laboratories Inc.
  14. 6.3.1 Enzyme Research Laboratories Inc. Company Information
  15. 6.3.2 Enzyme Research Laboratories Inc. Business Overview
  16. 6.3.3 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Enzyme Research Laboratories Inc. Human Coagulation Factor XIII Product Portfolio
  18. 6.3.5 Enzyme Research Laboratories Inc. Recent Developments
  19. 6.4 Invitrogen (Thermo Fisher Scientific Inc.)
  20. 6.4.1 Invitrogen (Thermo Fisher Scientific Inc.) Company Information
  21. 6.4.2 Invitrogen (Thermo Fisher Scientific Inc.) Business Overview
  22. 6.4.3 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Invitrogen (Thermo Fisher Scientific Inc.) Human Coagulation Factor XIII Product Portfolio
  24. 6.4.5 Invitrogen (Thermo Fisher Scientific Inc.) Recent Developments
  25. 6.5 Sino Biological, Inc.
  26. 6.5.1 Sino Biological, Inc. Company Information
  27. 6.5.2 Sino Biological, Inc. Business Overview
  28. 6.5.3 Sino Biological, Inc. Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sino Biological, Inc. Human Coagulation Factor XIII Product Portfolio
  30. 6.5.5 Sino Biological, Inc. Recent Developments
  31. 6.6 ZEDIRA GmbH
  32. 6.6.1 ZEDIRA GmbH Company Information
  33. 6.6.2 ZEDIRA GmbH Business Overview
  34. 6.6.3 ZEDIRA GmbH Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ZEDIRA GmbH Human Coagulation Factor XIII Product Portfolio
  36. 6.6.5 ZEDIRA GmbH Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Human Coagulation Factor XIII Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA Human Coagulation Factor XIII Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
7 North America by Country
  1. 7.1 North America Human Coagulation Factor XIII Sales by Country
  2. 7.1.1 North America Human Coagulation Factor XIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Coagulation Factor XIII Sales by Country (2021-2026)
  4. 7.1.3 North America Human Coagulation Factor XIII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Coagulation Factor XIII Market Size by Country
  6. 7.2.1 North America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Coagulation Factor XIII Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Coagulation Factor XIII Sales by Country
  2. 8.1.1 Europe Human Coagulation Factor XIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Coagulation Factor XIII Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Coagulation Factor XIII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Coagulation Factor XIII Market Size by Country
  6. 8.2.1 Europe Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Coagulation Factor XIII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Coagulation Factor XIII Sales by Country
  2. 9.1.1 Asia-Pacific Human Coagulation Factor XIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Coagulation Factor XIII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Coagulation Factor XIII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Coagulation Factor XIII Market Size by Country
  6. 9.2.1 Asia-Pacific Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Coagulation Factor XIII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Coagulation Factor XIII Sales by Country
  2. 10.1.1 South America Human Coagulation Factor XIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Coagulation Factor XIII Sales by Country (2021-2026)
  4. 10.1.3 South America Human Coagulation Factor XIII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Coagulation Factor XIII Market Size by Country
  6. 10.2.1 South America Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Coagulation Factor XIII Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Coagulation Factor XIII Sales by Country
  2. 11.1.1 Middle East and Africa Human Coagulation Factor XIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Coagulation Factor XIII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Coagulation Factor XIII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Coagulation Factor XIII Market Size by Country
  6. 11.2.1 Middle East and Africa Human Coagulation Factor XIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Coagulation Factor XIII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Coagulation Factor XIII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Coagulation Factor XIII Value Chain Analysis
  2. 12.1.1 Human Coagulation Factor XIII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Coagulation Factor XIII Production Mode & Process
  7. 12.2 Human Coagulation Factor XIII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Coagulation Factor XIII Distributors
  10. 12.2.3 Human Coagulation Factor XIII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst